Elenbaas, R M <br/><br/>
Subcutaneous epinephrine vs. nebulized metaproterenol in acute asthma.  [electronic resource] 

 -  Drug intelligence & clinical pharmacy   
 - 567-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0012-6578 
<br/><br/><label>Standard No.: </label>10.1177/106002808501900714  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Administration, Intranasal<br/>Adolescent<br/>Adult<br/>Aerosols<br/>Asthma--drug therapy<br/>Blood Pressure--drug effects<br/>Epinephrine--administration & dosage<br/>Female<br/>Heart Rate--drug effects<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Metaproterenol--administration & dosage<br/>Middle Aged<br/>Peak Expiratory Flow Rate